WuXi Biologics, Li Ning blocks raise combined HK$6.1bn

capsule px230
By Jonathan Breen
02 Apr 2020

Hong Kong saw a pair of block trades this week as WuXi Biologics Holdings offloaded HK$4.6bn ($599.4m) in WuXi Biologics (Cayman) stock and Viva China sold HK$1.51bn in Li Ning Co shares.

The Chinese biotechnology company came on Tuesday aiming to sell 41m secondary shares in WuXi Biologics, equal to 3.2% of the Hong Kong-listed subsidiary’s total share capital.

It offered the initial block with price guidance of HK$95.00 to HK$97.00 a share, eyeing proceeds of HK$3.9bn to HK$3.98bn. The ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial